Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH) that stimulates the release of human growth hormone (HGH). FDA-approved for body fat redistribution syndrome, Tesamorelin has shown powerful effects on fat loss, muscle preservation, nerve regeneration, and cognitive enhancement.
It is not a steroid and does not affect testosterone levels.
Benefits
- Reduces adipose fat tissue (especially in the abdomen and upper back)
- Targets visceral fat around internal organs (liver, stomach, intestines)
- Preserves and increases lean muscle mass
- Boosts metabolism and energy output
- Improves insulin sensitivity
- Reduces cholesterol and triglycerides
- Supports nerve regeneration after injury
- Increases neurotransmitters tied to cognitive performance
Possible Side Effects
- Injection site irritation (redness, swelling, itching)
- Muscle aches and pain
- Headache
- Nausea
- Diarrhea
- Sweating
Rare but More Serious Side Effects
- Diarrhea with fever and dehydration
- Shortness of breath
- Joint or muscle pain
- Numbness or tingling in the extremities
- May increase risk of Type-2 diabetes
Contraindications
Do not use Tesamorelin if:
- You’ve had pituitary tumors or surgery
- You have an active malignancy
- You’re allergic to mannitol
- You’re pregnant or breastfeeding
- You’ve had hypothalamic-pituitary axis disruption
- You have a diagnosed pituitary disorder
Reconstitution and Dosing
12-week cycle followed by a 4-week washout
Inject 5 days per week with 2 consecutive rest days
Dose at night, at least 90 minutes after your last meal
Subcutaneous Administration
TESAMORELIN: 10MG
Mix with 3mL (300 units) of BAC water
Standard Protocol
30 units (1mg), 1x/day, 5 days/week
Maximum Protocol
60 units (2mg), 1x/day, 5 days/ week
Tesamorelin: 20mg
Mix with 3mL (300 units) of BAC water
Standard Protocol
15 units (1mg), 1x/day, 5 days/week
Maximum Protocol
30 units (2mg), 1x/day, 5 days/week